SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Conway David I.) "

Sökning: WFRF:(Conway David I.)

  • Resultat 11-12 av 12
  • Föregående 1[2]
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
11.
  • Lang Kuhs, Krystle A, et al. (författare)
  • Human Papillomavirus 16 E6 Antibodies in Individuals Without Diagnosed Cancer: A Pooled Analysis.
  • 2015
  • Ingår i: Cancer Epidemiology Biomarkers & Prevention. - American Association for Cancer Research. - 1538-7755. ; 24:4, s. 683-689
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: The increasing incidence of oropharyngeal cancer in many developed countries has been attributed to human papillomavirus type 16 (HPV16) infections. Recently, HPV16 E6 serology has been identified as a promising early marker for oropharyngeal cancer. Therefore, characterization of HPV16 E6 seropositivity among individuals without cancer is warranted. Methods: 4,666 controls were pooled from several studies of cancer and HPV seropositivity, all tested within the same laboratory. HPV16 E6 seropositive controls were classified as having i) moderate (mean fluorescent intensity [MFI]≥484 & <1000) or ii) high seroreactivity (MFI≥1000). Associations of moderate and high HPV16 E6 seroreactivity with i) demographic risk factors; and seropositivity for ii) other HPV16 proteins (E1, E2, E4, E7 and L1) and iii) E6 proteins from non-HPV16 types (HPV6, 11, 18, 31, 33, 45 and 52) were evaluated. Results: Thirty-two (0.7%) HPV16 E6 seropositive controls were identified; 17 (0.4%) with moderate and 15 (0.3%) with high seroreactivity. High HPV16 E6 seroreactivity was associated with former smoking (odds ratio [OR] 5.5 [95% confidence interval [CI]:1.2-51.8]), and seropositivity against HPV16 L1 (OR 4.8, 95%CI:1.3-15.4); E2 (OR 7.7, 95%CI:1.4-29.1); multiple HPV16 proteins (OR 25.3, 95%CI:2.6-119.6 for 3 HPV16 proteins beside E6) and HPV33 E6 (OR 17.7, 95%CI:1.9-81.8). No associations were observed with moderate HPV16 E6 seroreactivity. Conclusions: High HPV16 E6 seroreactivity is rare among individuals without diagnosed cancer and was not explained by demographic factors. Impact: Some HPV16 E6 seropositive individuals without diagnosed HPV-driven cancer, especially those with seropositivity against other HPV16 proteins, may harbor a biologically relevant HPV16 infection.
  •  
12.
  • Urayama, Kevin Y., et al. (författare)
  • Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein-Barr Virus Status-Defined Subgroups
  • 2012
  • Ingår i: Journal of the National Cancer Institute. - 0027-8874 .- 1460-2105. ; 104:3, s. 240-253
  • Tidskriftsartikel (refereegranskat)abstract
    • Accumulating evidence suggests that risk factors for classical Hodgkin lymphoma (cHL) differ by tumor Epstein-Barr virus (EBV) status. This potential etiological heterogeneity is not recognized in current disease classification. We conducted a genome-wide association study of 1200 cHL patients and 6417 control subjects, with validation in an independent replication series, to identify common genetic variants associated with total cHL and subtypes defined by tumor EBV status. Multiple logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) assuming a log-additive genetic model for the variants. All statistical tests were two-sided. Two novel loci associated with total cHL irrespective of EBV status were identified in the major histocompatibility complex region; one resides adjacent to MICB (rs2248462: OR = 0.61, 95% CI = 0.53 to 0.69, P = 1.3 x 10(-13)) and the other at HLA-DRA (rs2395185: OR = 0.56, 95% CI = 0.50 to 0.62, P = 8.3 x 10(-25)) with both results confirmed in an independent replication series. Consistent with previous reports, associations were found between EBV-positive cHL and genetic variants within the class I region (rs2734986, HLA-A: OR = 2.45, 95% CI = 2.00 to 3.00, P = 1.2 x 10(-15); rs6904029, HCG9: OR = 0.46, 95% CI = 0.36 to 0.59, P = 5.5 x 10(-10)) and between EBV-negative cHL and rs6903608 within the class II region (rs6903608, HLA-DRA: OR = 2.08, 95% CI = 1.84 to 2.35, P = 6.1 x 10(-31)). The association between rs6903608 and EBV-negative cHL was confined to the nodular sclerosis histological subtype. Evidence for an association between EBV-negative cHL and rs20541 (5q31, IL13: OR = 1.53, 95% CI = 1.32 to 1.76, P = 5.4 x 10(-9)), a variant previously linked to psoriasis and asthma, was observed; however, the evidence for replication was less clear. Notably, one additional psoriasis-associated variant, rs27524 (5q15, ERAP1), showed evidence of an association with cHL in the genome-wide association study (OR = 1.21, 95% CI = 1.10 to 1.33, P = 1.5 x 10(-4)) and replication series (P = .03). Overall, these results provide strong evidence that EBV status is an etiologically important classification of cHL and also suggest that some components of the pathological process are common to both EBV-positive and EBV-negative patients.
Skapa referenser, mejla, bekava och länka
  • Resultat 11-12 av 12
  • Föregående 1[2]
Åtkomst
fritt online (5)
Typ av publikation
tidskriftsartikel (12)
Typ av innehåll
refereegranskat (12)
Författare/redaktör
Holcátová, Ivana (10)
Kjærheim, Kristina (8)
Conway, David I (8)
Brennan, Paul (8)
Agudo, Antonio (7)
Lagiou, Pagona (7)
visa fler...
Castellsague, Xavier (7)
Znaor, Ariana (7)
Healy, Claire M (7)
Ahrens, Wolfgang, (6)
Sánchez, Maria-José (6)
McKay, James D (6)
Clavel-Chapelon, Fra ... (5)
Riboli, Elio (5)
Boffetta, Paolo (5)
Lissowska, Jolanta (5)
Canova, Cristina (5)
Macfarlane, Tatiana ... (5)
Zaridze, David (5)
Foretova, Lenka (5)
Fabianova, Eleonora (5)
Gaborieau, Valerie (5)
Tjønneland, Anne (4)
Bueno-de-Mesquita, H ... (4)
Johansson, Mattias, (4)
Merletti, Franco (4)
Lathrop, Mark (4)
Anantharaman, Devase ... (4)
Simonato, Lorenzo (4)
Janout, Vladimir (4)
Bencko, Vladimir (4)
Richiardi, Lorenzo, (4)
Overvad, Kim (3)
Trichopoulou, Antoni ... (3)
Tjonneland, Anne (3)
Travis, Ruth C (3)
Trichopoulos, Dimitr ... (3)
González, Carlos A (3)
Larranaga, Nerea (3)
Polesel, Jerry (3)
Thomson, Peter (3)
Mates, Dana (3)
Rudnai, Peter (3)
Lubinski, Jan (3)
Zelenika, Diana (3)
Boland, Anne (3)
Szeszenia-Dabrowska, ... (3)
Vatten, Lars (3)
Hung, Rayjean J (3)
Franceschi, Silvia (3)
visa färre...
Lärosäte
Umeå universitet (7)
Lunds universitet (5)
Karolinska Institutet (4)
Uppsala universitet (3)
Chalmers tekniska högskola (2)
Linköpings universitet (1)
Språk
Engelska (12)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (9)
Naturvetenskap (2)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy